Zacks: Brokerages Expect Safeguard Scientifics, Inc (NYSE:SFE) Will Post Earnings of -$0.56 Per Share

Equities research analysts predict that Safeguard Scientifics, Inc (NYSE:SFE) will report earnings of ($0.56) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings of $1.56 per share in the same quarter last year, which would indicate a negative year over year growth rate of 135.9%. The firm is expected to issue its next quarterly earnings results on Thursday, October 24th.

On average, analysts expect that Safeguard Scientifics will report full-year earnings of $1.71 per share for the current year. For the next year, analysts anticipate that the business will post earnings of ($1.60) per share. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Safeguard Scientifics.

Safeguard Scientifics (NYSE:SFE) last announced its earnings results on Thursday, August 8th. The asset manager reported $1.75 EPS for the quarter, beating the consensus estimate of ($0.85) by $2.60.

Separately, ValuEngine raised Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a report on Thursday, August 8th.

Shares of NYSE SFE opened at $11.03 on Monday. Safeguard Scientifics has a 12 month low of $7.98 and a 12 month high of $12.91. The company has a market cap of $221.19 million, a price-to-earnings ratio of -14.51 and a beta of 0.85. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.02. The business has a fifty day simple moving average of $11.73 and a 200-day simple moving average of $11.73.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Captrust Financial Advisors lifted its holdings in shares of Safeguard Scientifics by 272.3% during the second quarter. Captrust Financial Advisors now owns 3,008 shares of the asset manager’s stock valued at $36,000 after purchasing an additional 2,200 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Safeguard Scientifics during the third quarter valued at $115,000. Spears Abacus Advisors LLC purchased a new stake in shares of Safeguard Scientifics during the second quarter valued at $202,000. Morgan Stanley lifted its holdings in shares of Safeguard Scientifics by 15.2% during the second quarter. Morgan Stanley now owns 19,979 shares of the asset manager’s stock valued at $241,000 after purchasing an additional 2,630 shares during the last quarter. Finally, NJ State Employees Deferred Compensation Plan lifted its stake in Safeguard Scientifics by 4.6% in the 2nd quarter. NJ State Employees Deferred Compensation Plan now owns 22,833 shares of the asset manager’s stock worth $275,000 after acquiring an additional 1,000 shares in the last quarter. 67.98% of the stock is owned by institutional investors and hedge funds.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Read More: What is a Special Dividend?

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.